LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration - Tilburg, Cornelis M. van; Kilburn, Lindsay B.; Perreault, Sébastien; Schmidt, Rene; Azizi, Amedeo A.; Cruz-Martínez, Ofelia; Zápotocký, Michal; Scheinemann, Katrin; Meeteren, Antoinette Y. N. Schouten-van; Sehested, Astrid; Opocher, Enrico; Driever, Pablo Hernáiz; et al. (BMC cancer, 2024)
Gesehen am 01.07.2024